APLN and pulmonary arterial hypertension: Previous work has shown that infusion of apelin is beneficial in a number of disease models of PAH [22] and HF [8], [9], [10], [23], [24], [25], but long term therapeutic efficacy is limited by a short half-life of a few minutes.